About ONCORESPONSE, INC
OncoResponse is a biotechnology company focused on discovering cancer immunotherapies by leveraging elite immune responses from patients who achieve exceptional responses to checkpoint inhibitor (CPI) therapies. The company aims to make 'cold' tumors 'hot' by relieving immunosuppression in the tumor microenvironment.
Discovery of authentic human antibodies using a clinically validated Technology PlatformDevelopment of monoclonal antibodies targeting immunosuppressive myeloid biologyLeveraging immune responses from Elite Cancer Responders to develop immunomodulatory antibodiesFocus on preclinical pipeline of monoclonal antibodies to remove brakes on immune cells in the tumor microenvironment
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to ONCORESPONSE, INC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.